{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:24:56Z","timestamp":1790958296405,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873142"],"award-info":[{"award-number":["81873142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Research Project for Practice Development of National TCM Clinical Research Bases","award":["Project no. JDZX2015202"],"award-info":[{"award-number":["Project no. JDZX2015202"]}]},{"name":"The (Double First-Class) and High-level University Discipline Reserve Talent Cultivation Program of Guangzhou University of Chinese Medicine","award":["Project No. A1-2601-23-415-111Z112"],"award-info":[{"award-number":["Project No. A1-2601-23-415-111Z112"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The impact of chronic arteriolar lesions on the prognosis of IgA nephropathy remains controversial. This study aims to explore the value of chronic arteriolar lesions of varying degrees in predicting the prognosis of IgA nephropathy patients and analyze the associated risk factors that contribute to the formation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A retrospective analysis was conducted on 853 patients diagnosed with IgA nephropathy through renal biopsy at Guangdong Provincial Hospital of Traditional Chinese Medicine between September 1, 2005, and December 31, 2021. Eventually, a total of 574 cases were included in this study. According to the degree of chronic arteriolar lesions, the patients were divided into four groups: no lesion group (n=115), mild lesion group (n=287), moderate lesion group (n=131), and severe lesion group (n=41). Relevant clinical and pathological features and renal outcomes were recorded. Kaplan-Meier analysis, Cox proportional hazards regression, and receiver operating characteristic (ROC) curve analysis were utilized to examine the relationship between different degrees of chronic arteriolar lesions and the prognosis of IgA nephropathy. Additionally, risk factors associated with the development of moderate to severe chronic arteriolar lesions were identified.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Worse clinical and pathological features were observed in the moderate to severe lesions group (P&lt;0.05). Moderate to severe chronic arteriolar lesions (aHR=3.357, 95%CI: 1.018\u201311.071, P=0.047), creatinine, S1, E1, T2, and C2 were identified as independent risk factors for adverse renal outcomes. Cox multivariate regression analysis on moderate to severe chronic arteriolar lesions demonstrated that creatinine, T2, and C2 were independent risk factors for adverse renal outcomes in patients with moderate to severe chronic arteriolar lesions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Moderate to severe chronic arteriolar lesions independently increases the risk of adverse renal outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0320635","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T17:59:19Z","timestamp":1745517559000},"page":"e0320635","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Moderate to severe chronic arteriolar lesions is an independent risk factor for adverse renal outcomes in IgA nephropathy"],"prefix":"10.1371","volume":"20","author":[{"given":"Qian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1227-6100","authenticated-orcid":true,"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haokai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3182-7276","authenticated-orcid":true,"given":"Chuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"2","key":"pone.0320635.ref001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.ajkd.2023.08.007","article-title":"The Treatment of Primary IgA Nephropathy: Change, Change, Change","volume":"83","author":"DJ Caster","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"pone.0320635.ref002","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/13543784.2022.2160315","article-title":"IgA nephropathy: an overview of drug treatments in clinical trials","volume":"31","author":"H Selvaskandan","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"pone.0320635.ref003","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.2015.322","article-title":"The MEST score provides earlier risk prediction in lgA nephropathy","volume":"89","author":"SJ Barbour","year":"2016","journal-title":"Kidney Int"},{"issue":"5","key":"pone.0320635.ref004","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"H Trimarchi","year":"2017","journal-title":"Kidney Int"},{"issue":"5","key":"pone.0320635.ref005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.ajkd.2019.03.416","article-title":"Microangiopathic Lesions in IgA Nephropathy: A Cohort Study","volume":"74","author":"Q Cai","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"pone.0320635.ref006","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ekir.2022.03.028","article-title":"The Role of Complement in Microangiopathic Lesions of IgA Nephropathy","volume":"7","author":"J Li","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"4","key":"pone.0320635.ref007","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/ndt\/gfh716","article-title":"Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy","volume":"20","author":"J Wu","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"pone.0320635.ref008","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility","volume":"76","author":"Society Working Group of the International IgA Nephropathy Network and the Renal Pathology","year":"2009","journal-title":"Kidney Int"},{"key":"pone.0320635.ref009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejim.2023.07.007","article-title":"Clinicopathological characteristics, risk factors and prognostic value of intrarenal vascular lesions in IgA nephropathy","volume":"117","author":"Y Ruan","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"6","key":"pone.0320635.ref010","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0272-6386(97)90472-8","article-title":"Prognostic indicators of progressive renal disease in IgA nephropathy: emergence of a new histologic grading system","volume":"29","author":"SM Lee","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"pone.0320635.ref011","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0272-6386(12)80595-6","article-title":"Microvascular disease and the progression of IgA nephropathy","volume":"15","author":"R Katafuchi","year":"1990","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"pone.0320635.ref012","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"LC Racusen","year":"1999","journal-title":"Kidney Int"},{"issue":"2","key":"pone.0320635.ref013","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1159\/000489290","article-title":"Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy","volume":"43","author":"Y Zhang","year":"2018","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"pone.0320635.ref014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.ajkd.2019.01.026","article-title":"Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial","volume":"74","author":"L-J Liu","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"pone.0320635.ref015","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1111\/j.1600-6143.2008.02370.x","article-title":"The Maryland aggregate pathology index: a deceased donor kidney biopsy scoring system for predicting graft failure","volume":"8","author":"RB Munivenkatappa","year":"2008","journal-title":"Am J Transplant"},{"issue":"4S","key":"pone.0320635.ref016","first-page":"S1","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","author":"Group Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"pone.0320635.ref017","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.ASN.0000103869.08096.4F","article-title":"Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial","volume":"15","author":"C Pozzi","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"pone.0320635.ref018","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.ajkd.2008.07.029","article-title":"Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial","volume":"53","author":"J Lv","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"pone.0320635.ref019","first-page":"209","article-title":"Kidney Disease\u2014Improving Glocal Outcomes (KDIGO) clinical practice guideline for glomerulonephritis. Chapter 10: IgA nephropathy","volume":"2","author":"International Society of Nephrology","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"23","key":"pone.0320635.ref020","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive Supportive Care plus Immunosuppression in IgA Nephropathy","volume":"373","author":"T Rauen","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0320635.ref021","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2017.9362","article-title":"Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial","volume":"318","author":"J Lv","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"pone.0320635.ref022","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/j.ajkd.2016.11.027","article-title":"Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial","volume":"69","author":"J-H Hou","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"pone.0320635.ref023","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2022.03.027","article-title":"Clinicopathological characteristics of high-altitude polycythemia-related kidney disease in Tibetan inhabitants","volume":"102","author":"H Wang","year":"2022","journal-title":"Kidney Int"},{"issue":"1","key":"pone.0320635.ref024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nep.12339","article-title":"Arteriolar hyalinosis and arterial hypertension as possible surrogate markers of reduced interstitial blood flow and hypoxia in glomerulonephritis","volume":"20","author":"C Bazzi","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"pone.0320635.ref025","doi-asserted-by":"crossref","first-page":"761897","DOI":"10.3389\/fmed.2021.761897","article-title":"Arterial-Arteriolar Sclerosis Is Independently Associated With Poor Renal Outcome in IgA Nephropathy Patients","volume":"8","author":"L Dong","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"pone.0320635.ref026","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1053\/ajkd.2001.22087","article-title":"Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease","volume":"37","author":"DH Kang","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"pone.0320635.ref027","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ndt\/gfh584","article-title":"Uric acid correlates with the severity of histopathological parameters in IgA nephropathy","volume":"20","author":"J Myllym\u00e4ki","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"pone.0320635.ref028","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41440-018-0026-4","article-title":"Night-time activation of the intrarenal renin-angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive IgA nephropathy patients","volume":"41","author":"N Ohashi","year":"2018","journal-title":"Hypertens Res"},{"issue":"6","key":"pone.0320635.ref029","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cjp2.234","article-title":"Severity of arterial and\/or arteriolar sclerosis in IgA nephropathy and the effects of renin-angiotensin system inhibitors on its prognosis","volume":"7","author":"N Sugiura","year":"2021","journal-title":"J Pathol Clin Res"},{"issue":"1","key":"pone.0320635.ref030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1291\/hypres.29.15","article-title":"Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy","volume":"29","author":"R Ikee","year":"2006","journal-title":"Hypertens Res"},{"issue":"1","key":"pone.0320635.ref031","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-6143.2012.04304.x","article-title":"Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure","volume":"13","author":"M Naesens","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"pone.0320635.ref032","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1471-4914(02)02405-X","article-title":"Pathogenic significance of IgA receptor interactions in IgA nephropathy","volume":"8","author":"RC Monteiro","year":"2002","journal-title":"Trends Mol Med"},{"key":"pone.0320635.ref033","doi-asserted-by":"crossref","first-page":"1224631","DOI":"10.3389\/fimmu.2023.1224631","article-title":"Machine learning in predicting T-score in the Oxford classification system of IgA nephropathy","volume":"14","author":"L-L Xu","year":"2023","journal-title":"Front Immunol"},{"issue":"10","key":"pone.0320635.ref034","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/ars.2017.7066","article-title":"Lipid Deposition in Kidney Diseases: Interplay Among Redox, Lipid Mediators, and Renal Impairment","volume":"28","author":"H Su","year":"2018","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"pone.0320635.ref035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/ijms21010190","article-title":"Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules","volume":"21","author":"K Hosokawa","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7","key":"pone.0320635.ref036","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/febs.14038","article-title":"Atgl deficiency induces podocyte apoptosis and leads to glomerular filtration barrier damage","volume":"284","author":"W Chen","year":"2017","journal-title":"FEBS J"},{"key":"pone.0320635.ref037","doi-asserted-by":"crossref","first-page":"877794","DOI":"10.3389\/fendo.2022.877794","article-title":"Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG\/HDL-C) in IgA Nephropathy Patients","volume":"13","author":"G Pei","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"pone.0320635.ref038","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000516187","article-title":"Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology","volume":"52","author":"Z Lin","year":"2021","journal-title":"Am J Nephrol"},{"issue":"2","key":"pone.0320635.ref039","first-page":"189","article-title":"Fibrinogen and Atherosclerosis","volume":"108","author":"L Cerit","year":"2017","journal-title":"Arq Bras Cardiol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T17:59:29Z","timestamp":1745517569000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320635"}},"subtitle":[],"editor":[{"given":"Wisit","family":"Kaewput","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0320635","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}